Cyfluthrin .: H113-27/2016-17E-PDF
"An evaluation of available scientific information has determined that under the currently labelled conditions of use, the human health risks estimated for cyfluthrin meet current standards for most uses. As a requirement for the continued registration of cyfluthrin, new risk-reduction measures are proposed for the commercial-class end-use products registered in Canada. Based on potential risks of concern for residential exposure, all domestic-class products are proposed for cancellation and some residential uses are also proposed to be removed. Consideration of any additional data/information submitted during the consultation period to further refine the health risk assessment may or may not result in a change to this proposal"--Overview.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.824615&sl=0
| Department/Agency |
|
|---|---|
| Title | Cyfluthrin . |
| Variant title |
|
| Series title |
|
| Publication type | Monograph - View Master Record |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 118 p. |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: